Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 713674, 7 pages
Research Article

Radiosensitization Effect of Nedaplatin on Nasopharyngeal Carcinoma Cells in Different Status of Epstein-Barr Virus Infection

1Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing 210009, China
2Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing 210009, China
3Jilin Cancer Hospital, Changchun 130012, China
4Department of Oncology, Xuzhou Medical College, Xuzhou 221004, China

Received 4 February 2014; Accepted 15 April 2014; Published 12 May 2014

Academic Editor: Tsair-Fwu Lee

Copyright © 2014 Li Yin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. C. Chan, E. C. Hung, J. K. Woo et al., “Early detection of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA analysis in a surveillance program,” Cancer, vol. 119, no. 10, pp. 1838–1844, 2013. View at Google Scholar
  2. A. W. Lee, W. T. Ng, Y. H. Chan, H. Sze, C. Chan, and T. H. Lam, “The battle against nasopharyngeal cancer,” Radiotherapy and Oncology, vol. 104, no. 3, pp. 272–278, 2012. View at Google Scholar
  3. K. P. Chang, N. M. Tsang, C. T. Liao et al., “Prognostic significance of18F-FDG PET parameters and plasma epstein-barr virus DNA load in patients with nasopharyngeal carcinoma,” Journal of Nuclear Medicine, vol. 53, no. 1, pp. 21–28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. X. Hou, C. Zhao, Y. Guo et al., “Different clinical significance of pre- and post-treatment plasma Epstein-Barr virus DNA load in nasopharyngeal carcinoma treated with radiotherapy,” Clinical Oncology, vol. 23, no. 2, pp. 128–133, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Shimada, H. Itamochi, and J. Kigawa, “Nedaplatin: a cisplatin derivative in cancer chemotherapy,” Cancer Management and Research, vol. 5, pp. 67–76, 2013. View at Google Scholar
  6. S. Samarghandian, J. T. Afshari, and S. Davoodi, “Chrysin reduces proliferation and induces apoptosis in the human prostate cancer cell line pc-3,” Clinics, vol. 66, no. 6, pp. 1073–1079, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. L. H. Yang, Y. Han, G. Li et al., “Axin gene methylation status correlates with radiosensitivity of lung cancer cells,” BMC Cancer, vol. 13, article 368, 2013. View at Publisher · View at Google Scholar
  8. K. Jingu, H. Matsushita, K. Takeda et al., “Long-term results of radiotherapy combined with nedaplatin and 5-fluorouracil for postoperative loco-regional recurrent esophageal cancer: update on a phase II study,” BMC Cancer, vol. 12, article 542, 2012. View at Google Scholar
  9. F. Oshita, M. Sugiura, S. Murakami, T. Kondo, H. Saito, and K. Yamada, “Phase II study of nedaplatin and irinotecan in patients with extensive small-cell lung cancer,” Cancer Chemotherapy and Pharmacology, vol. 71, no. 2, pp. 345–350, 2013. View at Google Scholar
  10. Y. Hamada, H. Naitoh, Y. Niibe et al., “Initial analysis of relationship between plasma platinum concentration and hematological adverse reaction associated with weekly chemotherapy using nedaplatin in combination with radiotherapy for cervical carcinoma,” European Journal of Gynaecological Oncology, vol. 31, no. 5, pp. 517–521, 2010. View at Google Scholar · View at Scopus
  11. S. A. Nahas and R. A. Gatti, “DNA double strand break repair defects, primary immunodeficiency disorders, and ‘radiosensitivity’,” Current Opinion in Allergy and Clinical Immunology, vol. 9, no. 6, pp. 510–551, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. T. Yip, R. K. Ngan, A. H. Fong, and S. C. Law, “Application of circulating plasma/serum EBV DNA in the clinical management of nasopharyngeal carcinoma,” Oral Oncology, 2014. View at Publisher · View at Google Scholar
  13. J. Y. Chan and S. T. Wong, “The role of plasma Epstein-Barr virus DNA in the management of recurrent nasopharyngeal carcinoma,” Laryngoscope, vol. 124, no. 1, pp. 126–130, 2014. View at Google Scholar
  14. Y. M. D. Lo, L. Y. S. Chan, K. W. Lo et al., “Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma,” Cancer Research, vol. 59, no. 6, pp. 1188–1191, 1999. View at Google Scholar · View at Scopus
  15. J. Chen, C. F. Hu, J. H. Hou et al., “Epstein-Barr virus encoded latent membrane protein 1 regulates mTOR signaling pathway genes which predict poor prognosis of nasopharyngeal carcinoma,” Journal of Translational Medicine, vol. 8, article 30, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. J. Yu, W. L. Hsu, R. M. Pfeiffer et al., “Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families,” Clinical Cancer Research, vol. 17, no. 7, pp. 1906–1914, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Q. Tang, Q. Y. Chen, W. Fan et al., “Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging,” Journal of Clinical Oncology, vol. 31, no. 23, pp. 2861–2869, 2013. View at Google Scholar
  18. E. Selzer and A. Hebar, “Basic principles of molecular effects of irradiation,” Wiener Medizinische Wochenschrift, vol. 162, no. 3-4, pp. 47–54, 2012. View at Google Scholar
  19. M. Toyoshima, “Analysis of p53 dependent damage response in sperm-irradiated mouse embryos,” Journal of Radiation Research, vol. 50, no. 1, pp. 11–17, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Hiro, Y. Inoue, Y. Toiyama et al., “Possibility of paclitaxel as an alternative radiosensitizer to 5-fluorouracil for colon cancer,” Oncology Reports, vol. 24, no. 4, pp. 1029–1034, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Zheng, W. Tang, F. Wei et al., “Radiation-inducible protein RbAp48 contributes to radiosensitivity of cervical cancer cells,” Gynecologic Oncology, vol. 130, no. 3, pp. 601–608, 2013. View at Google Scholar
  22. J. R. Williams, Y. Zhang, H. Zhou et al., “Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution,” International Journal of Radiation Biology, vol. 84, no. 2, pp. 151–164, 2008. View at Publisher · View at Google Scholar · View at Scopus